. However, toxicity of those extremely powerful PKC agonists is definitely an ongoing problem, as well as necessity to provide the medications through injection. At this time, artificial analogs of bryostatin58,59 and prostratin60 are increasingly being explored, with minimized toxicity and value of synthesis as opposed with their natural source https://rylanflptn.mdkblog.com/35298113/the-fitc-dextran-60842-46-8-mw-4000-diaries